SBS - the best value in QMS software

Change of Manufacturing Location

E

elleseo

#1
Hello,

Our company is preparing a dossier for getting CE mark.
Let me give you detail situation.

There are two facilities (A, B (x 7 times scale up) and the distance is only 20 minutes by a car.
Our product is classified to Class III, but is not registred.
We conducted a clinical trial to support our indication and several non-clinical testings with a product from the facility A (There is no clinical/nonclinical data from the facility B). A couple of the non-chlinical tests are not satisfied the MD regulation.
All validations related the process, quality will be done in the facility B.

Here are my basic questions.
Our company will be register the facility B for commercical products.
For this, we will filed all data, CMC, clinical/non-clinical data in facility A and stability data in facility B. In addition, the equivalent data (manufacturing process and quality) between two facilities will be included.

Question No.1
The non-clinical tests not meet to the regulation will be included after doing new tests with the product manufactured from the facility B in case of we verify the equivalance.
Will it be possible for registration as a regulatory aspect?
Do we have to do the non-clinical tests with the product produced from the facility A?

Question No.2
What is the best way to register our product using all data we have?
I know some tests must be performed, but I don't think the clinical test will be not.

I hope you can help me a lot.
Thanks.

Elleseo
 
Elsmar Forum Sponsor

somashekar

Staff member
Super Moderator
#2
Hi Eelleseo.
Thanks for your good question and welcome to the Cove.
While someone expert with the EU regulations will pitch in, my advice to you is to open up all your questions with your NB.... for your NB is the one who provides the gateway to the EU with the CE mark.
 
E

elleseo

#3
Thanks for your reply.
You are right, but our NB is not a good responsor. It takes too long to give us the reponse to us.
 

RobertvanBoxtel

Involved In Discussions
#4
Best approach (as indicated to be followed by you):
Identify for each tests which products (from what site) are used.
Demonstrate through testing which ER is covered (or more)
In case product tested comes from A, argue how it covers the final design specifications. Same applies to products tested from site B.

In case you need more detailed guidance, I am afraid you need to provide more detailed information.
 

RobertvanBoxtel

Involved In Discussions
#6
Transferring from one site to the other requires a lot of evidence to demonstrate continuous control.
And to be able to demonstrate something, yes, documentation is needed. Because if you cannot demonstrte it on paper (or electronically), it ain't done...
 

pkost

Trusted Information Resource
#7
My thoughts on this are as follows:

the locations of manufacture are somewhat irrelevant at this stage as the device is not approved; you must be able to show/prove (and this is no different from if you were using the same site):

1. The products you manufacture for the clinical study at site A are as intended by the design specification (otherwise how you you prove the design is safe/effective)
2. Your device that is manufactured as intended by the design spec is safe and effective (this is the purpose of the clinical evaluation
3. The product you manufacture at the main production site (B) comply with the design specification that was used as part of the clinical evaluation (i.e. the product continues to be safe and effective)

The main concern of the notified body will be "how do you know that product produced at site B is the same as the product at site A"

Things to consider (this is not a complete list)
- are all components sourced from the same place, do they go through the same or more rigorous inspection checks
- are all the in process controls the same (or more rigorous)
- is the batch release criteria the same?
- is packaging the same specification
- is the sterility still assured?
- is equipment calibrated to the necessary level
 
Thread starter Similar threads Forum Replies Date
N Is a new 510K required for change of manufacturing location for an existing device? US Food and Drug Administration (FDA) 1
M Change in Manufacturing, Assembly and Testing Location to a Sub-Contractor 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
S Medical Devices - Change of Manufacturing Location US Food and Drug Administration (FDA) 5
R Medical Device - Change manufacturing plant Design and Development of Products and Processes 6
Q Legal Manufacturing Address Change – multiple registrations at same address 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
N China - Start manufacturing before change approval? China Medical Device Regulations 1
B Manufacturing Company Address Change - implications for FDA Other US Medical Device Regulations 1
M FDA News USFDA Final Guidance – Manufacturing Site Change Supplements: Content and Submission Medical Device and FDA Regulations and Standards News 1
Ajit Basrur FDA News FDA Guidance Document: Manufacturing Site Change Supplement US Food and Drug Administration (FDA) 0
S Change notice while switching to injection molding technique for manufacturing EU Medical Device Regulations 1
H FDA/PMA/Medical Device/Before submission/Manufacturing facility change US Food and Drug Administration (FDA) 1
J How to change the Manufacturing Site to another Contract Manufacturer Japan Medical Device Regulations 1
V Product Evaluation Requirements for Change in Manufacturing Facility/Change in Design 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 12
T Initiating Cultural Change in a Small Manufacturing Company Quality Manager and Management Related Issues 4
D AS9100 Scope Change to Include Manufacturing Services AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 5
A Temporary Change of Manufacturing Site - Notified Body Notification Requirements EU Medical Device Regulations 3
K Need help with AS9100 Scope Change to include Manufacturing Process Maps, Process Mapping and Turtle Diagrams 1
R Change in Direction - Management decides to Outsource Manufacturing Operations ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 8
R PMA (Parts Manufacturing Approval) Supplement - Labeling Software Change 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
A Concession/ Deviation for change in manufacturing process IATF 16949 - Automotive Quality Systems Standard 1
K 8.2.3.1 Monitoring and measurement of manufacturing processes - Tool change IATF 16949 - Automotive Quality Systems Standard 5
A Lean Manufacturing - How do I change my company's Culture? Lean in Manufacturing and Service Industries 26
U Power supply - Change From 160 to 300 Watts - Significant change? EU Medical Device Regulations 0
N Sterilization Protocol Change in Validation Process and further impacts ISO 13485:2016 - Medical Device Quality Management Systems 1
M Label change - 510(k) Medical Device and FDA Regulations and Standards News 5
M EMS change management ISO 14001:2015 Specific Discussions 2
E Document Change Request forms (or no forms)? ISO 13485:2016 - Medical Device Quality Management Systems 3
J Significant change related to design and intended use EU Medical Device Regulations 2
J Need Change Control Yes/No Decision Tree Template ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 1
S Cleaning process center change ISO 13485:2016 - Medical Device Quality Management Systems 4
U NOC - What is considered a "design change" EU Medical Device Regulations 5
qualprod What do CB´s change when doing a partial moving ? ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 1
Y Algo change significancy Medical Information Technology, Medical Software and Health Informatics 3
Revision36 Engineering Change Order Industry Standards Other Medical Device and Orthopedic Related Topics 4
Z Iterative development and FDA change requests IEC 62304 - Medical Device Software Life Cycle Processes 12
D ECO (Engineering Change Order) process questions ISO 13485:2016 - Medical Device Quality Management Systems 7
Tagin Template or Checklist for Process Change Document Control Systems, Procedures, Forms and Templates 5
R Do we need issue ECN (Engineering Change Notice) towards updated Material Specification? Design and Development of Products and Processes 2
A What does this line from MDCG 2020-3 (MDR art. 120 substantial change) mean to you? EU Medical Device Regulations 4
M Change management procedure when 7.3 is not applicable ISO 13485:2016 - Medical Device Quality Management Systems 5
D Change Approval Requirements - Does every change need formal customer approval? Design and Development of Products and Processes 17
Q Change the shape of the raw material FAI AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 5
D Engineering Change Order (ECO) metrics to track ISO 13485:2016 - Medical Device Quality Management Systems 6
P Notified Body Approval of Change EU Medical Device Regulations 2
F Change to Formulation due to Reach (China Medical Device Regulations) China Medical Device Regulations 0
E Change in control plan - Do I have to do sampling? IATF 16949 - Automotive Quality Systems Standard 1
S Forced ServiceNow validation - No change in our current user and functional requirements IT (Information Technology) Service Management 6
M Address change for a company with CE/ISO13485 EU Medical Device Regulations 2
G Need to change KPI we called NC parts (maximum 3%.) to FTQ (first time quality) IATF 16949 - Automotive Quality Systems Standard 4
J FDA notification of address change US Food and Drug Administration (FDA) 2

Similar threads

Top Bottom